Bavarian Nordic A/S

PINK:BVNKF USA Biotechnology
Market Cap
$1.62 Billion
Market Cap Rank
#5587 Global
#3276 in USA
Share Price
$20.71
Change (1 day)
-4.12%
52-Week Range
$20.71 - $24.23
All Time High
$58.02
About

Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an or… Read more

Bavarian Nordic A/S (BVNKF) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.098x

Based on the latest financial reports, Bavarian Nordic A/S (BVNKF) has a cash flow conversion efficiency ratio of 0.098x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.29 Billion) by net assets ($13.16 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Bavarian Nordic A/S - Cash Flow Conversion Efficiency Trend (2001–2024)

This chart illustrates how Bavarian Nordic A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Bavarian Nordic A/S Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bavarian Nordic A/S ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Bavarian Nordic A/S (2001–2024)

The table below shows the annual cash flow conversion efficiency of Bavarian Nordic A/S from 2001 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $11.41 Billion $1.95 Billion 0.171x +57.90%
2023-12-31 $10.34 Billion $1.12 Billion 0.108x +251.70%
2022-12-31 $7.15 Billion $220.05 Million 0.031x +163.31%
2021-12-31 $7.37 Billion $-358.50 Million -0.049x -141.60%
2020-12-31 $4.89 Billion $571.91 Million 0.117x +179.00%
2019-12-31 $1.87 Billion $-275.91 Million -0.148x -11.78%
2018-12-31 $2.18 Billion $-288.53 Million -0.132x -253.48%
2017-12-31 $2.51 Billion $216.06 Million 0.086x -35.01%
2016-12-31 $2.02 Billion $267.60 Million 0.133x +69.09%
2015-12-31 $1.34 Billion $105.32 Million 0.078x -71.00%
2014-12-31 $1.25 Billion $338.75 Million 0.271x +79.58%
2013-12-31 $976.29 Million $147.08 Million 0.151x +649.29%
2012-12-31 $999.68 Million $20.10 Million 0.020x +106.47%
2011-12-31 $1.21 Billion $-375.24 Million -0.311x -4.99%
2010-12-31 $810.43 Million $-239.86 Million -0.296x +56.95%
2009-12-31 $704.21 Million $-484.14 Million -0.687x -3214.05%
2008-12-31 $1.02 Billion $22.41 Million 0.022x -83.52%
2007-12-31 $1.22 Billion $163.16 Million 0.134x +147.63%
2006-12-31 $691.40 Million $-194.49 Million -0.281x -204.50%
2005-12-31 $630.10 Million $-58.21 Million -0.092x +61.98%
2004-12-31 $315.39 Million $-76.63 Million -0.243x -40386.52%
2003-12-31 $347.00 Million $209.27K 0.001x +100.86%
2002-12-31 $196.44 Million $-13.71 Million -0.070x +96.69%
2001-12-31 $44.14 Million $-93.12 Million -2.109x --